(NEW YORK)--With new coronavirus cases spiking in parts of the US now may be time to revisit face mask and PPE providers for possible play on renewed COVID-19 outbreak.
Recent data shows coronavirus cases are starting spiking in several US states including Utah, Arizona, Texas, Florida, and North Carolina. With protests continuing across the US we could see an even bigger spike in COVID-19 cases in the coming days, which could put Personal Protective Equipment (PPE) stocks back on trader wish list.
Below are three face mask and PPE providers traders should watch.
Lakeland Industries (LAKE)
Lakeland recently saw its stock soar after reporting that sales and profits for their protective gear remained strong amid the ongoing Covid-19 outbreak. Now with data showing a new spike in Coronavirus cases in several US states the outlook for demand for PPE may have only increased that much more.
Lakeland CEO Charles Roberson commented that, "Our fiscal 2021 first quarter performance was extraordinary with record setting financial results that validate our belief that owning our own manufacturing and having a resilient supply chain are essential to being a global leader in the PPE (personal protection equipment) market."
Alpha Pro Tech (APT)
The postive news from LAKE helped spill over to this other popular face mask and PPE provider, Alpha Pro Tech. In April, APT saw its stock soared after seeing an "exponential" jump in orders even into 2021.
Ludlow Research made note to their subscribers that LAKE positive earnings, positive demand for face masks and PPE, and increased cases of COVID-19 in Western US could put APT in-play in the short-term. The firm issued a speculative target fo $20+ based on growing cases of COVID-19, strong product demand outlook, and potential increase in retail demand from traders.
GTX Corp (GTXO)
GTXO recently announce that the Company's GPS SmartSole and Personal Protective Equipment (PPE) products were now available for purchase on the General Services Administration (GSA) Schedule. As a member of the SoCal Bio Partnership for Pandemics Countermeasure Taskforce, GTXO is using its extensive manufacturing experience to source and distribute U.S. Food and Drug Administration ('FDA') and European CE mark certified PPE across its wide network of channel partners in order to make available products that are in high demand.
While many traders were riding the reopening plays, which were great traders to say the least, the renewed spike on COVID-19 cases could swing retail interest out of those plays and back towards COVID plays, such as face mask and PPE providers.
How far these new cases increase is yet to be determined, but with recent re openings and protests across the country we could see cases increase faster in coming days, which could put renewed buyer interest in this sector.
Trader Madness and has over 25 years experience trading in the small cap. To get updates on the next new trading idea please register here
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. In Compliance with SEC Rule 17B WSNC was compensated fine hundred thousand restrricted shares of GTXO, through its parent company, for development of AI and application development, and this should be a conflict of interest when reviewing this material. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial adviser before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial adviser before making any and all investment decisions when investing in these type of securities
- Dynavax (DVAX) Receives $27M Vaccine Purchase Order from CDC - July 1, 2020
- As COVID-19 Cases Spike Look to PPE Stocks: $LAKE $APT $GTXO - June 15, 2020
- Spike in COVID Cases May Spell Risk Off for Overvalued Stocks and Markets - June 7, 2020
- Riot Blockchain (RIOT) a Hedge on Inflation as Bitcoin Rallies - May 13, 2020
- Stock Valuations Could Set Stage for Potential Bubble Burst - May 9, 2020
- Centennial Resource (CDEV) Boosts Liquidity $468M as WTI Crude Breaks Above $20 Barrel - May 4, 2020
- Companies Should Prepare IT Spending to Thrive in New Normal - April 16, 2020
- Great Elm Capital (GEC) Provides Ventilators and Respiratory Care Equipment - April 15, 2020
- FujiFilm (FUJIY) to Ramp Up Production of Avigan for Treatment of COVID19 - April 15, 2020
- GTX Corp (GTXO) Begins Selling KN95 Face Masks for Coronavirus Outbreak - April 8, 2020